Lexology January 13, 2022
European Union, United Kingdom, USA
Introduction
The global life sciences industry is evolving at an extraordinary rate. Scientists are rapidly gaining insights into fundamental biologic processes and novel cures. Cutting-edge developments and basic science are transforming medicines, medical devices, and diagnostic tools. Industry participants are collaborating to bring products to market in novel ways, and sophisticated investors are fueling this remarkable set of developments. Healthcare products are being delivered to patients worldwide through complex channels, and being reimbursed through an array of payors. As a result, the industry today is vastly different from what it was even five years ago, and it will be vastly different five years from now.
The pace of technological development is unprecedented and offers the...
Today's Sponsors
Today's Sponsor